Arysta Acquisition Gets EU Approval

The acquisition of Arysta LifeScience Corp. by private equity firm Permira was approved by the European Commission (EC), according to a Reuters article.

The $2.2 billion purchase of the Japanese company was approved by the US Federal Trade Commission in November.

Advertisement

The EC said it had found no problems with the deal among direct competitors or in the supply chain.

Hide picture